| Application no. and date | 12739509.3 (espacenet) (Federated) (European Patent Register), 20120127 | | Patent/reg. no. and date | DK/EP 2667715, 20170719 | | Publication date | 20131204 | | Priority no. and date | US 201161462141 P, 20110127, US 201161492248 P, 20110601 | | EP pub. no. and date |
EP 2667715 20131204 | | Effective date | | | Applicant/owner | Neuren Pharmaceuticals Limited, Lowndes Jordan
Level 15 PWC Tower
188 Quay Street
Auckland 1141, NZ | | Applicant ref. no. | P81703772DK00E | | Inventor | GLASS, Larry, 7410 Piney Branch Road
Takoma Park
Maryland 20912, US,
BICKERDIKE, Michael John, 41 Waimarie Street
St. Heliers
Auckland, NZ,
SNAPE, Michael Frederick, 111 Thorkhill Road
Thames Ditton
Surrey KT7 0UW, GB | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A01N 43/64 (2006.01) , A61K 31/401 (2006.01) , A61K 31/41 (2006.01) , A61K 38/06 (2006.01) , A61K 45/06 (2006.01) , A61K 9/00 (2006.01) , A61K 9/127 (2006.01) , A61P 25/00 (2006.01) | | Title | BEHANDLING AF AUTISMESPEKTRUMFORSTYRRELSER VED ANVENDELSE AF
GLYCYL-L-2-METHYLPROLYL-L-GLUTAMINSYRE | | Int. application no. | US2012000047 | | Int. publication no. | WO2012102832 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
